Market Share of Europe Insulin Drugs Industry
The European insulin drug market is highly consolidated in nature due to the presence of only a few major companies operating globally as well as regionally. Mergers and acquisitions between players in the recent past have helped companies strengthen their market presence. Eli Lilly and Boehringer Ingelheim have an alliance to develop and commercialize Abasaglar (Insulin Glargine).
Europe Insulin Drugs Market Leaders
Novo Nordisk
Sanofi
Eli Lilly
AstraZeneca
Biocon
*Disclaimer: Major Players sorted in no particular order
